Stock Events

Stock Events

Design Therapeutics (DSGN) Q1 2026 Earnings

9MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.35

-0.33

-0.3

-0.27

Details

Expected EPS

-0.354

Actual EPS

-0.27

Surprise EPS

0.08

Surprise Percent

+23.73%

Description

Design Therapeutics (DSGN) has reported earnings of -0.27 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.